(S)-Lactic acid approved for use as an active substance in biocidal products under the BPR (EU)
The European Commission has approved (S)-lactic acid for use as active substance in biocidal products in product types 2, 3, and 4 under the EU's Biocidal Products Regulation (BPR). The published approval date is 1st May 2019. To comply with this important regulation, Corbion's customers will need to submit an application for specific authorization for any of their biocidal products containing (S)-lactic acid (previously called L(+) lactic acid), by 1st May 2019.
If the product is already marketed according to national regulations in the transitional period and fulfills the description above (existing products PT2, 3 or 4), the dossier must be submitted by 1st May 2019, or before. Otherwise, the product must be removed from the market after the approval date (phase-out period). If the product is not yet marketed (new products PT2, 3 or 4), the dossier can be submitted after 1st May 2019. In this case, however, the biocidal product can only be marketed after authorization has been granted.
The product types are:
· PT2 - disinfectants and algaecides not intended for direct application
to humans or animals.
· PT3 - veterinary hygiene.
· PT4 - food and feed areas.
Approval is subject to compliance with certain specifications and conditions.
Details are published in the Official Journal of the European Union.
In 2007, Corbion (via its legal entity, Purac Biochem bv) submitted an application for review of (S)-lactic acid as active substance in biocidal products in PT's 2, 3 and 4. This evaluation was carried out in the context of the work program for the review of existing active substances provided for in Article 89 of the BPR (No 528/2012). Germany was designated as Rapporteur Member State to carry out the assessment on basis of the dossiers submitted by Corbion. On 3rd May 2016, Germany submitted an assessment report and the conclusions of its evaluation to the ECHA (European Chemicals Agency). The ECHA BPC's Final (positive) Opinion was published on 27th April 2017.
For more information, please contact:
Evelien Bikker, Global Marketing Coordinator
+31 (0)183 695 695, Evelien.firstname.lastname@example.org
Analysts and investors:
Jeroen van Harten, Director Investor Relations
+31 (0)20 590 6293, +31(0)6 21 577 086
Corbion is the global market leader in lactic acid, lactic acid derivatives, and a leading company in emulsifiers, functional enzyme blends, minerals, vitamins and algae ingredients. We develop sustainable ingredient solutions to improve the quality of life for people today and for future generations. For over 100 years, we have been uncompromising in our commitment to safety, quality, innovation and performance. Drawing on our deep application and product knowledge, we work side-by-side with customers to make our cutting edge technologies work for them. Our solutions help differentiate products in markets such as food, home & personal care, animal nutrition, pharmaceuticals, medical devices, and bioplastics. In 2016, Corbion generated annual sales of € 911.3 million and had a workforce of 1,684 FTE. Corbion is listed on Euronext Amsterdam. For more information: www.corbion.com.
Product not available in your region
This product is not available in the selected region.
If you want this product in your region, or find a suitable alternative, please contact us,